COVID-19 Resources

Due to the high number of inquiries received and the continuous developments regarding the virus, TAG is offering COVID-19 Retainer Packages to businesses concerned with the impact of this outbreak.

Request a quote below or call us: 1-800-401-2239

For the food industry

  • Daily Updates

  • Advice for Food Industry

  • What can you (we) all do?

Key Points

Updated: April 20, 2020

In recent days, the CDC has updated their list of primary symptoms for COVID-19 to include: chills, repeated shaking with chills, muscle pain, headache, sore throat, new loss of taste or smell.

As such, TAG is updating its General Screening Questionnaire by moving those symptoms up to primary symptoms. 

General Screening Questions

  1. Employee’s first name:

  2. Is the employee experiencing or showing symptoms in the last 24 hours?

    • Primary symptoms:

      • Fever?

      • Cough?

      • Difficulty breathing?

      • Chills

      • Repeated shaking with chills

      • Muscle pain

      • Headache

      • Sore throat

      • Anosmia (loss of smell or taste)

    • Secondary symptoms:

      • Tiredness or fatigue

      • Sore throat

      • Gastrointestinal illness (diarrhea)

  3. Has the employee been exposed to a person (someone in their household, intimate partner, or close-contact) with symptomatic COVID-19 during period from 48 hours before symptoms onset until meeting the criteria for discontinuing home isolation?   This can be a laboratory-confirmed disease or a clinically compatible illness (fever, cough, or shortness of breath) in a state or territory with widespread community transmission). If so, please explain.

    • How and when did the exposure happen?


You can now find all our downloadable resources available online (for free) here. This includes posters and infographics for the following:

  • Social Distancing Posters (in English, Spanish, Portuguese, French, Chinese, and Vietnamese)

  • Best Practices for Mask Usage (in English, Spanish)

  • Preventive Controls & Preventive Measures (in English, Spanish)

  • Preventive Control Hierarchy Pyramid (in English, Spanish, and Portuguese)

Please let us know if you have any material requests or additional language. Additionally, we have differing formats for screen-viewing, print-viewing, gray-scale, and other formats (upon request).

Please find the resources to download, here!

If you have any trouble with any of the resources, please contact us to let us know!

April 17 Update: Based on both scientific research and anecdotal evidence, there is increasing credible evidence for anosmia (loss of sense of smell) to be a symptom of COVID-19. Earlier this month, based on research from ENT UK and the American Society of Otolaryngology, we recommended that wellness screenings include anosmia as a secondary symptom. With further scientific evidence published this week, we have, once more, updated our recommendations to include questions focused on loss of smell as part of a Wellness Screening Question (for Employees and Visitors):

1.     If loss of smell is reported (not related to allergies, congestion, etc.), send the person home to self-quarantine.

2.     At this point, we do not recommend that close contacts be sought or sent home.


We will continue to follow the science and update our recommendations if and as applicable.

Recommendations for
the Food Industry

TAG Recommends Caution in Antibody Testing

COVID-19 antibody tests have hit the market and are being touted as a way of enabling U.S. companies to safely bring people back to work. Despite this promise, TAG recommends companies practice caution when considering using antibody testing as a screening method to allow workers back.

One type of test, serological antibody tests, detect the IgM and IgG antibodies (IgM and IgG are different types are antibodies) that show up in the blood of those who were infected with the COVID-19 virus. The antibodies, themselves, could be a marker of immunity. However, because of the unreliable accuracy of the tests, and limited understanding of the extent of immunity, TAG advises caution.

 Some issues surrounding the use of antibody tests, include:

  • In March, the FDA began to allow antibody tests to be sold without formal federal review or approval as long as development companies were able to validate their own results and would notify the FDA that they had done so. However various tests are proving to be far less than accurate, including those noted in a New York Times article, which officials found to have a 20% reliability, rather than the 93%-97% the company claimed.

  • Even FDA-authorized tests have shown a 5% false positive (meaning: individuals test positive for having had COVID-19 when they really did not have it), which can be significant in a facility of hundreds. As such, FDA itself is recommending caution in using antibody tests.

  • Additionally, because our understanding of COVID-19 is still evolving, we do not know the extent of immunity a person develops after being infected with the virus. Although some viruses provide long-term or life-long immunity, others do not. As this is a fairly new disease, it is unknown how long immunity may last for a recovered coronavirus patient or what concentration of antibodies is needed to build up the immunity.

More critically, businesses wishing to conduct antibody testing on employees must consider “what to do after the test results”? Because of the current chance of false positives, the tests could potentially create a false sense of security of immunity to the virus.

In addition, TAG does not recommend relaxing social distancing or mask recommendations for persons who test positive for antibodies. Regardless of antibody testing results, best practices for controlling the spread of COVID-19 should not change.

Everyone should practice social distancing (more specifically, physical distancing), not only those who are ill or at higher-risk (e.g. older individuals, pre-existing conditions) but also among healthy individuals so we may "flatten the curve".


Please feel free to use this free poster at your establishment. Please email us ( for a copy of this poster (English, Spanish, Portuguese, French, and Chinese - simplified, traditional are available).

Outbreak Updates

As of April 20, 2020 (16:14 ET), there are over 2,458,000 cases (>168,000 deaths) worldwide.


Due to the increasing number of cases in the United States, TAG will move from reporting counts per country to focusing on the United States, please see here for the data. For further information regarding worldwide numbers, please refer to John Hopkin University’s aggregate map.

Keep up to date with COVID-19:

Please send us any questions, comments, and/or concerns! We are happy to talk with you. 


OR call us at 1-800-401-2239

Get the Insights & Guidance You Need! 

Learn how TAG can help your company ensure food safety and brand protection.

Contact us today!


Toll free 800.401.2239

  • White Twitter Icon
  • White LinkedIn Icon

Join our e-mail list to receive

our weekly Industry Insights!

© 2020 The Acheson Group. All Rights Reserved.